Dreamed Diabetes

Dreamed Diabetes
Pioneering artificial pancreas technology and developing AI-driven decision-support tools for diabetes management.
About
Technology stack
detected 2026-06-26No comments yet. Be the first to share your take.
What does Dreamed Diabetes do?
Founded in 2014, DreaMed Diabetes developed the first artificial pancreas technology. The company now focuses on creating AI-driven decision-support tools for diabetes management, holding the world's first FDA clearance for such a system.
How much funding has Dreamed Diabetes raised?
Dreamed Diabetes has raised a total of $33M in funding. The most recent round on record is Series B.
Where is Dreamed Diabetes headquartered?
Dreamed Diabetes is headquartered in Petah Tikva, Israel.
When was Dreamed Diabetes founded?
Dreamed Diabetes was founded in 2014.
What industry does Dreamed Diabetes operate in?
Dreamed Diabetes operates in Healthcare, Disease Management, Prevention, Diabetes Pancrease, HealthTech, MedTech.
How many employees does Dreamed Diabetes have?
Dreamed Diabetes has approximately 27 people on record.
What is Dreamed Diabetes's revenue?
StartupHub estimates Dreamed Diabetes's annual revenue at $8.9M (range $4.7M to $14.1M, 63% confidence), based on comparable companies in the sector.
What is Dreamed Diabetes's valuation?
StartupHub estimates Dreamed Diabetes's effective valuation at $141.6M (range $83.5M to $200.4M, 16% confidence), based on comparable companies in the sector.